SPONSOR

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Total Trials

Recruiting

Phases

Phase 1, Phase 2

Conditions studied: Carotid Artery Diseases Haemodynamic Monitoring NSCLC Stage IV Sex Disorder Hypogonadism, Male Erectile Dysfunction Hand Eczema Lung Cancer Breast Cancer Kidney Cancer

Fondazione Policlinico Universitario Agostino Gemelli IRCCS is a clinical research sponsor with 36 registered studies on ClinicalTrials.gov, of which 36 are actively recruiting participants. Research covers conditions including Carotid Artery Diseases, Haemodynamic Monitoring, NSCLC Stage IV, Sex Disorder.

The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Fondazione Policlinico Universitario Agostino Gemelli IRCCS

How many clinical trials has Fondazione Policlinico Universitario Agostino Gemelli IRCCS sponsored?

ClinicalMetric currently tracks 36 clinical trials sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS, of which 36 are actively recruiting participants. These trials cover conditions including Carotid Artery Diseases, Haemodynamic Monitoring, NSCLC Stage IV. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Fondazione Policlinico Universitario Agostino Gemelli IRCCS research focus on?

Fondazione Policlinico Universitario Agostino Gemelli IRCCS clinical trials span Carotid Artery Diseases, Haemodynamic Monitoring, NSCLC Stage IV, Sex Disorder, Hypogonadism, Male, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Fondazione Policlinico Universitario Agostino Gemelli IRCCS clinical trial?

To participate in a Fondazione Policlinico Universitario Agostino Gemelli IRCCS trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials with current recruitment status updated daily.

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Frequently Asked Questions — Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Clinical Trials by Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Hemodynamic Monitoring Carotid Surgery

ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer

Immune Signature of Chronic Hand Eczema Unveiled by Spatial Transcriptomics and Single-Cell Proteomics

Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.

Solid Tumors in RASopathies

Predictive Factors for Survival in Aggressive Meningiomas

Role of MRI in the Evaluation of Hepatic Metastases of Colorectal Cancer

Hemodynamic Instability of Patient With Spontaneous Subarachnoid Hemorrhage

O2 Consumption And CO2 Production After Hemodynamic Optimization In Shock

EvoLution of Neoadjuvant TreatMent in 'Triple-negative' or 'HER-2-positive' Breast Cancer Diagnosed in the EaRly Phase

Helmet NIV vs. CPAP vs. High-flow Nasal Oxygen in Hypoxemic Respiratory Failure

Neurodevelopmental Outcome in Newborn With Hypoxic-ischemic Encephalopathy Treated With Therapeutic Hypothermia

Hemodynamic Optimization Using an Artificial Intelligenze System

Ultrasound and Respiratory Physiological Signals in Lung Diseases

Ultrasound Image Bank: Advancing Medical Research and Diagnostics

Stigma and Psychological profilE in REctal-anal caNcer pAtients

No-Stoma Policy in Advanced Ovarian Cancer Surgery

Trustworthy Artificial Intelligence for Improvement of Stroke Outcomes

Observational Monocentric Study on Biliary Tract Cancer (BABEL)

Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases

Effectiveness and Tolerance of IV vs SC Biological Drugs in Gastrointestinal Diseases

SEQUENTIAL PROFILING OF TUMOR-DERIVED CIRCULATING CELL-FREE DNA (ctDNA) IN ADVANCED OVARIAN CANCER PATIENTS

AIRFRAME: Artificial Intelligence for Recognition of Fetal bRain AnoMaliEs at Second Trimester Fetal Brain Scan

Mitral Valve Annulus Assessment, Multimodality Imaging

Natural History and Prognosis of Pediatric Epilepsies With Different Etiology

Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma

HF vs NIV in Acute Cardiogenic Pulmonary Edema

Comparison of Bone Mineral Density in the Third Trimester Between Women in Singleton and Twin Pregnancies Using Questionnaires and REMS Densitometric Examination

Early Visual Functions in Patients at Risk of Developing Cerebral Visual Impairment. A Pilot Study

Psychological and Psychiatric prOfile in Glioblastoma and Head and Neck Cancer

Technological Balance and Gait Rehabilitation in Patients With Multiple Sclerosis.

FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach

Prospective Evaluation of the Role of MRI in Ovarian Masses During Pregnancy

Impact of Trans-catheter Aortic Valve Implantation on Renal Function

Prognosis in Adult Patients With Congenital Heart Disease

Noninvasive Ventilation Facemasks Favoring Carbon Dioxide Washout